Financings In the third quarter of 2013, start-up companies brought in $559.4 million. Of the total, 67% or $377.2 million was attributed to biopharma fundraising. Medical device firms raised 56% less
IN VITRO DIAGNOSTICS Mergers & Acquisitions Metamark Genetics Inc. Endo Health Solutions Inc. HealthTronics Inc. HealthTronics Laboratory Solutions Endo International PLC (branded and generic drug